Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BurnsAdler Pharmaceuticals has announced that Collatamp EG has received marketing approval from ANVISA, National Agency for Surveillance in Brazil.
Subscribe to our email newsletter
Collatamp EG is a fully resorbable gentamicin-impregnated collagen sponge, used as a surgical implant for local haemostasis of capillary, parenchymatous and seeping hemorrhages in areas with a high risk of infection. BurnsAdler will be co-marketing Collatamp EG with its local partner Meizler Biopharma.
Bryan Somerville, COO of BurnsAdler, said: “CollatampEG is claimed to be the only gentamycin-impregnated collagen sponge in the world, and allows medical providers to reduce patient costs and mean duration of hospital stay. Through our strategic partnership with Meizler and direct promotional efforts, we look forward to positive results in Brazil.”